About HS Code 300431
HS 300431 specifically covers medicaments containing insulin, packaged for retail sale. This category is vital for the global management of diabetes, encompassing various types of insulin (e.g., rapid-acting, long-acting, intermediate-acting) in different delivery formats such as vials, cartridges, and pre-filled pens. These life-saving medications are traded internationally by major pharmaceutical companies to distributors, pharmacies, and healthcare systems worldwide. The trade is characterized by high demand, significant research and development investment, and strict cold chain logistics to maintain product integrity. Regulatory approvals are crucial for market access, and pricing often remains a contentious issue globally, impacting patient access. The continuous innovation in insulin formulations and delivery devices drives ongoing international trade and competition in this specialized pharmaceutical segment.
Products Under This Code
Insulin glargine injection, Insulin aspart injection, Insulin detemir injection, Human insulin isophane suspension, Insulin lispro injection, Insulin regular injection, Insulin degludec injection
Real World Examples
Lantus, Novolog, Levemir, Humulin N, Humalog, Apidra
Common Misclassification
Could be confused with 300439 if it contains other hormones, or 300331 if insulin is in bulk form and not packaged for retail sale.
Products Classified Under 3004.31
Industry
This code belongs to the Chemicals industry.
Trade Overview
Denmark (Novo Nordisk), France (Sanofi), and the USA (Eli Lilly) are leading exporters, serving a global patient population.
Frequently Asked Questions
What is HS code 300431?
HS code 300431 covers: Medicaments; containing insulin, for therapeutic or prophylactic uses, packaged for retail sale. HS 300431 specifically covers medicaments containing insulin, packaged for retail sale. This category is vital for the global management of diabetes, encompassing various types of insulin (e.g., rapid-acting, long-acting, intermediate-acting) in different delivery formats such as vials, cartridges, and pre-filled pens. These life-saving medications are traded internationally by major pharmaceutical companies to distributors, pharmacies, and healthcare systems worldwide. The trade is characterized by high demand, significant research and development investment, and strict cold chain logistics to maintain product integrity. Regulatory approvals are crucial for market access, and pricing often remains a contentious issue globally, impacting patient access. The continuous innovation in insulin formulations and delivery devices drives ongoing international trade and competition in this specialized pharmaceutical segment.
What products fall under HS code 300431?
Insulin glargine injection, Insulin aspart injection, Insulin detemir injection, Human insulin isophane suspension, Insulin lispro injection, Insulin regular injection, Insulin degludec injection
What are common misclassifications for HS code 300431?
Could be confused with 300439 if it contains other hormones, or 300331 if insulin is in bulk form and not packaged for retail sale.
How is HS code 300431 structured?
HS code 300431 is a 6-digit subheading under the Harmonized System. The first 2 digits (30) identify the chapter, digits 3-4 (04) identify the heading, and digits 5-6 (31) specify the subheading. This code is standardized globally by the World Customs Organization.